By expanding the source of proteins related to HTR1B, the study further enriches the evidence, particularly for the possibility of developing the HTR1B pathway as a therapeutic target for migraine and other related disorders in future investigations and therapies. This evidence concerns the gene HTR1B and migraine disorder.